N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrazin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]phenyl]acetamide

C76H76N20O6 — CID 165109119

IUPACN-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrazin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]phenyl]acetamide
SMILESCn1cc(-c2ccc3c(-c4ccc(CC(=O)Nc5cc(C(C)(C)C)on5)cc4)cnn3c2)cn1.Cn1cc(-c2cn3ncc(-c4ccc(CC(=O)Nc5cc(C(C)(C)C)on5)cc4)c3cn2)cn1.Cn1cc(-c2cnc3c(-c4ccc(CC(=O)Nc5cc(C(C)(C)C)on5)cc4)cnn3c2)cn1
InChIInChI=1S/C26H26N6O2.2C25H25N7O2/c1-26(2,3)23-12-24(30-34-23)29-25(33)11-17-5-7-18(8-6-17)21-14-28-32-16-19(9-10-22(21)32)20-13-27-31(4)15-20;1-25(2,3)21-10-22(30-34-21)29-23(33)9-16-5-7-17(8-6-16)20-13-28-32-15-18(11-26-24(20)32)19-12-27-31(4)14-19;1-25(2,3)22-10-23(30-34-22)29-24(33)9-16-5-7-17(8-6-16)19-12-28-32-15-20(26-13-21(19)32)18-11-27-31(4)14-18/h5-10,12-16H,11H2,1-4H3,(H,29,30,33);2*5-8,10-15H,9H2,1-4H3,(H,29,30,33)
InChIKeyZQNNMMJNZWAXLB-UHFFFAOYSA-N
MW1365.58 g/mol
LogP13.40
Rot. Bonds15

About N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrazin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]phenyl]acetamide

N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrazin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]phenyl]acetamide (PubChem CID 165109119) has the molecular formula C76H76N20O6 and a molecular weight of 1365.58 g/mol. Its IUPAC name is N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrazin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]phenyl]acetamide.

Molecular Properties

Compound NameN-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrazin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]phenyl]acetamide
PubChem CID165109119
Molecular FormulaC76H76N20O6
Molecular Weight1365.58 g/mol
Exact Mass1364.63
IUPAC NameN-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrazin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]phenyl]acetamide
SMILESCn1cc(-c2ccc3c(-c4ccc(CC(=O)Nc5cc(C(C)(C)C)on5)cc4)cnn3c2)cn1.Cn1cc(-c2cn3ncc(-c4ccc(CC(=O)Nc5cc(C(C)(C)C)on5)cc4)c3cn2)cn1.Cn1cc(-c2cnc3c(-c4ccc(CC(=O)Nc5cc(C(C)(C)C)on5)cc4)cnn3c2)cn1
InChIInChI=1S/C26H26N6O2.2C25H25N7O2/c1-26(2,3)23-12-24(30-34-23)29-25(33)11-17-5-7-18(8-6-17)21-14-28-32-16-19(9-10-22(21)32)20-13-27-31(4)15-20;1-25(2,3)21-10-22(30-34-21)29-23(33)9-16-5-7-17(8-6-16)20-13-28-32-15-18(11-26-24(20)32)19-12-27-31(4)14-19;1-25(2,3)22-10-23(30-34-22)29-24(33)9-16-5-7-17(8-6-16)19-12-28-32-15-20(26-13-21(19)32)18-11-27-31(4)14-18/h5-10,12-16H,11H2,1-4H3,(H,29,30,33);2*5-8,10-15H,9H2,1-4H3,(H,29,30,33)
InChIKeyZQNNMMJNZWAXLB-UHFFFAOYSA-N
XLogP13.40
TPSA296.53 Ų
H-Bond Donors3
H-Bond Acceptors23
Rotatable Bonds15
Heavy Atoms102
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001365.58
LogP ≤ 513.40
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1023

Analyze N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrazin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]phenyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrazin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]phenyl]acetamide?
The IUPAC name of N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrazin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]phenyl]acetamide (CID 165109119) is N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrazin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]phenyl]acetamide.
What is the SMILES notation for N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrazin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]phenyl]acetamide?
The canonical SMILES for N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrazin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]phenyl]acetamide is Cn1cc(-c2ccc3c(-c4ccc(CC(=O)Nc5cc(C(C)(C)C)on5)cc4)cnn3c2)cn1.Cn1cc(-c2cn3ncc(-c4ccc(CC(=O)Nc5cc(C(C)(C)C)on5)cc4)c3cn2)cn1.Cn1cc(-c2cnc3c(-c4ccc(CC(=O)Nc5cc(C(C)(C)C)on5)cc4)cnn3c2)cn1.
What is the InChIKey of N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrazin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]phenyl]acetamide?
The InChIKey is ZQNNMMJNZWAXLB-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H26N6O2.2C25H25N7O2/c1-26(2,3)23-12-24(30-34-23)29-25(33)11-17-5-7-18(8-6-17)21-14-28-32-16-19(9-10-22(21)32)20-13-27-31(4)15-20;1-25(2,3)21-10-22(30-34-21)29-23(33)9-16-5-7-17(8-6-16)20-13-28-32-15-18(11-26-24(20)32)19-12-27-31(4)14-19;1-25(2,3)22-10-23(30-34-22)29-24(33)9-16-5-7-17(8-6-16)19-12-28-32-15-20(26-13-21(19)32)18-11-27-31(4)14-18/h5-10,12-16H,11H2,1-4H3,(H,29,30,33);2*5-8,10-15H,9H2,1-4H3,(H,29,30,33).
What are the key properties of N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrazin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]phenyl]acetamide?
N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrazin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]phenyl]acetamide has a molecular weight of 1365.58 g/mol, XLogP of 13.40, 15 rotatable bonds, 3 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrazin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]phenyl]acetamide;N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]phenyl]acetamide is sourced from PubChem (CID 165109119), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).